Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Witters

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Journal of Gastroenterology and Hepatology|September 18, 2007
Congenital veno-venous malformations of the liver: widely variable clinical presentationsPeter Witters, Geert Maleux, Christophe George, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 28, 2020
Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDGPeter Witters, Shawn Tahata, Rita Barone, et al.
Orphanet Journal of Rare Diseases|December 14, 2022
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year resultsGeorge A Diaz, Roberto Giugliani, Nathalie Guffon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Orphanet Journal of Rare Diseases|May 3, 2018
Liver transplantation for very severe hepatopulmonary syndrome due to vitamin A-induced chronic liver disease in a patient with Shwachman-Diamond syndromeGiorgia Bucciol, David Cassiman, Tania Roskams, et al.
The FEBS Journal|November 14, 2018
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase BLise Boon, Estefania Ugarte-Berzal, Erik Martens, et al.
Cellular and Molecular Life Sciences : CMLS|June 27, 2025
Glycosphingolipid synthesis is impaired in SLC35A2-CDG and improves with galactose supplementationAndrea Jáñez Pedrayes, Sam De Craemer, Jakub Idkowiak, et al.
Clinical Genetics|June 24, 2021
Expanding the phenotypic spectrum of FINCA (fibrosis, neurodegeneration, and cerebral angiomatosis) syndrome beyond infancyChristina K Rapp, Ine Van Dijck, Lucia Laugwitz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 19, 2022
TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disabilitySilvia Radenkovic, Diego Martinelli, Yuebo Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 22, 2017
Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelinesJoaquim Calvo-Lerma, Jessie M Hulst, Inês Asseiceira, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology and Hepatology|September 18, 2007
Congenital veno-venous malformations of the liver: widely variable clinical presentationsPeter Witters, Geert Maleux, Christophe George, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 28, 2020
Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDGPeter Witters, Shawn Tahata, Rita Barone, et al.
Orphanet Journal of Rare Diseases|December 14, 2022
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year resultsGeorge A Diaz, Roberto Giugliani, Nathalie Guffon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Orphanet Journal of Rare Diseases|May 3, 2018
Liver transplantation for very severe hepatopulmonary syndrome due to vitamin A-induced chronic liver disease in a patient with Shwachman-Diamond syndromeGiorgia Bucciol, David Cassiman, Tania Roskams, et al.
The FEBS Journal|November 14, 2018
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase BLise Boon, Estefania Ugarte-Berzal, Erik Martens, et al.
Cellular and Molecular Life Sciences : CMLS|June 27, 2025
Glycosphingolipid synthesis is impaired in SLC35A2-CDG and improves with galactose supplementationAndrea Jáñez Pedrayes, Sam De Craemer, Jakub Idkowiak, et al.
Clinical Genetics|June 24, 2021
Expanding the phenotypic spectrum of FINCA (fibrosis, neurodegeneration, and cerebral angiomatosis) syndrome beyond infancyChristina K Rapp, Ine Van Dijck, Lucia Laugwitz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 19, 2022
TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disabilitySilvia Radenkovic, Diego Martinelli, Yuebo Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 22, 2017
Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelinesJoaquim Calvo-Lerma, Jessie M Hulst, Inês Asseiceira, et al.
Pageof 8